Tajima Masato, Hayama Atsushi, Rai Tatemitsu, Sasaki Sei, Uchida Shinichi
Department of Nephrology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Biochem Biophys Res Commun. 2007 Nov 3;362(4):858-64. doi: 10.1016/j.bbrc.2007.08.097. Epub 2007 Aug 27.
ClC-K chloride channels belong to the CLC chloride channel family and play an important role in transepithelial chloride transport in the kidney. To be functional, ClC-K channels need to be translocated to the plasma membranes after synthesis; the translocation requires the binding to its beta-subunit, barttin. The binding interaction between barttin and ClC-K channels has not been characterized, although the crystal structure of CLC was resolved. In the present study, we sought to clarify the binding sites of barttin in ClC-K2 by co-immunoprecipitation and immunofluorescence microscopy using various ClC-K2 mutants. The deletion of the carboxy-terminal portion of ClC-K2 up to leucine 91, a construct which contains the B domain alone, showed the binding ability to barttin. Since the CLC channel forms an internal antiparallel structure, domain J corresponds to domain B in the carboxy-terminal half of ClC-K. Accordingly, we made the carboxy-terminal half of ClC-K2 containing domain J and thereafter and its deletion mutants, and performed a similar co-immunoprecipitation study. As a result, only domain J was enough for binding to barttin. Immunofluorescence microscopy confirmed that the domains B and J as well as the full length ClC-K2 could be localized to the plasma membranes only when co-expressed with barttin. These results showed that barttin was able to bind to the domains that constitute the outer lateral surfaces of ClC-K2. This information regarding the binding sites will be useful for designing a new class of diuretics or anti-hypertensive agents that inhibit the interaction of ClC-K and barttin.
ClC-K氯离子通道属于CLC氯离子通道家族,在肾脏的跨上皮氯离子转运中起重要作用。为发挥功能,ClC-K通道在合成后需要转运至质膜;这种转运需要与它的β亚基barttin结合。尽管CLC的晶体结构已解析,但barttin与ClC-K通道之间的结合相互作用尚未明确。在本研究中,我们试图通过使用各种ClC-K2突变体的免疫共沉淀和免疫荧光显微镜技术来阐明barttin在ClC-K2中的结合位点。缺失ClC-K2直至亮氨酸91的羧基末端部分,即仅包含B结构域的构建体,显示出与barttin的结合能力。由于CLC通道形成内部反平行结构,J结构域对应于ClC-K羧基末端一半中的B结构域。因此,我们制备了包含J结构域及其后部分的ClC-K2羧基末端一半及其缺失突变体,并进行了类似的免疫共沉淀研究。结果表明,仅J结构域就足以与barttin结合。免疫荧光显微镜证实,只有在与barttin共表达时,B结构域、J结构域以及全长ClC-K2才能定位于质膜。这些结果表明,barttin能够与构成ClC-K2外侧表面的结构域结合。有关结合位点的这些信息将有助于设计一类新型利尿剂或抗高血压药物,以抑制ClC-K与barttin之间的相互作用。